Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)

Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles

(2012) Bao-Rui Liu   International Journal of Nanomedicine

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer

(2012) Satoshi Inoue et al.   PLoS One

Exploiting the Cancer Genome: Strategies for the Discovery and Clinical Development of Targeted Molecular Therapeutics

(2011) Timothy A. Yap et al.   Annual Review of Pharmacology and Toxicology

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

(2011) Hai Wang et al.   BIOMATERIALS

Polymalic Acid–Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity

(2011) Satoshi Inoue et al.   CANCER RESEARCH

Treatment advances for glioblastoma

(2011) Eric T Wong et al.   Expert Review of Neurotherapeutics

Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)

(2010) Rameshwar Patil et al.   PHARMACEUTICAL RESEARCH

Inhibition of brain tumor growth by intravenous poly( -L-malic acid) nanobioconjugate with pH-dependent drug release

(2010) H. Ding et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Design and development of polymer conjugates as anti-angiogenic agents

(2009) Ehud Segal et al.   ADVANCED DRUG DELIVERY REVIEWS

Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters

(2009) V Martin et al.   ONCOGENE